Yield10 Bioscience Stock Analysis

Yield10 Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 20.14. Yield10 Bioscience last dividend was issued on the 16th of January 2020. The entity had 1:24 split on the 3rd of May 2024. Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts. Yield10 Bioscience operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 29 people. For more information please call Oliver Peoples at (617) 583-1700 or visit https://www.yield10bio.com.

Yield10 Bioscience Investment Alerts

Yield10 Bioscience Upcoming and Recent Events

Yield10 Largest EPS Surprises

View All Earnings Estimates

Yield10 Stock Institutional Investors

Note, although Yield10 Bioscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Yield10 Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 345.46 K.

Yield10 Profitablity

Management Efficiency

Yield10 Bioscience has return on total asset (ROA) of (1.7811) % which means that it has lost $1.7811 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.0809) %, meaning that it created substantial loss on money invested by shareholders. Yield10 Bioscience's management efficiency ratios could be used to measure how well Yield10 Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Yield10 Bioscience's Return On Capital Employed is very stable compared to the past year. As of the 21st of January 2025, Return On Equity is likely to grow to 5.50, though Return On Tangible Assets are likely to grow to (4.04). At this time, Yield10 Bioscience's Non Current Assets Total are very stable compared to the past year. As of the 21st of January 2025, Non Currrent Assets Other is likely to grow to about 388.3 K, while Total Assets are likely to drop about 3.3 M.

Technical Drivers

As of the 21st of January, Yield10 Bioscience maintains the Market Risk Adjusted Performance of (2.24), mean deviation of 16.09, and Standard Deviation of 25.76. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Yield10 Bioscience, as well as the relationship between them.

Yield10 Bioscience Price Movement Analysis

Yield10 Bioscience Insider Trading Activities

Yield10 Bioscience Outstanding Bonds

Yield10 Bioscience Predictive Daily Indicators

Yield10 Bioscience Forecast Models

Yield10 Bioscience's time-series forecasting models are one of many Yield10 Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Yield10 Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Yield10 Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Yield10 shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Yield10 Bioscience. By using and applying Yield10 Stock analysis, traders can create a robust methodology for identifying Yield10 entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Yield10 analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Yield10 analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Yield10 Bioscience stock analysis indicators help investors evaluate how Yield10 Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Yield10 Bioscience shares will generate the highest return on investment. By understating and applying Yield10 Bioscience stock analysis, traders can identify Yield10 Bioscience position entry and exit signals to maximize returns.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Yield10 Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.